{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:25:22Z","timestamp":1761395122078,"version":"3.37.3"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Science and Technology of China","award":["2017YFD0501504"],"award-info":[{"award-number":["2017YFD0501504"]}]},{"name":"Special Program for Common and Key Technological Innovations of Key Industries in Chongqing","award":["cstc2016zdcy-ztzx10001"],"award-info":[{"award-number":["cstc2016zdcy-ztzx10001"]}]},{"name":"Chongqing Municipal Agricultural Commission","award":["2017[5]"],"award-info":[{"award-number":["2017[5]"]}]},{"DOI":"10.13039\/501100006250","name":"Southwest University","doi-asserted-by":"publisher","award":["SZ201703","HZ201601"],"award-info":[{"award-number":["SZ201703","HZ201601"]}],"id":[{"id":"10.13039\/501100006250","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["XDJK2017D143"],"award-info":[{"award-number":["XDJK2017D143"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hunan University of Medicine","award":["2014KY03"],"award-info":[{"award-number":["2014KY03"]}]},{"name":"Science and Technology Plan Projects of Huaihua","award":["2014-18"],"award-info":[{"award-number":["2014-18"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.lfs.2017.11.012","type":"journal-article","created":{"date-parts":[[2017,11,11]],"date-time":"2017-11-11T07:16:54Z","timestamp":1510384614000},"page":"259-269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["8-Cetylberberine inhibits growth of lung cancer in vitro and in vivo"],"prefix":"10.1016","volume":"192","author":[{"given":"Yubo","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meimei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3016-719X","authenticated-orcid":false,"given":"Xuegang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lfs.2017.11.012_bb0005","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1440-1681.2012.05695.x","article-title":"Anti-inflammatory treatment in patients after percutaneous coronary intervention: another potential use for berberine?","volume":"39","author":"Fan","year":"2012","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2017.11.012_bb0010","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijpharm.2016.09.089","article-title":"Delivery system for berberine chloride based on the nanocarrier ZnAl-layered double hydroxide: physicochemical characterization, release behavior and evaluation of anti-bacterial potential","volume":"515","author":"Djebbi","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.lfs.2017.11.012_bb0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000445618","article-title":"Berberine improved aldo-induced podocyte injury via inhibiting oxidative stress and endoplasmic reticulum stress pathways both in vivo and in vitro","volume":"39","author":"Wang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"issue":"5","key":"10.1016\/j.lfs.2017.11.012_bb0020","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.metabol.2008.01.013","article-title":"Efficacy of berberine in patients with type 2 diabetes mellitus","volume":"57","author":"Yin","year":"2008","journal-title":"Metab. Clin. Exp."},{"issue":"4","key":"10.1016\/j.lfs.2017.11.012_bb0025","first-page":"334","article-title":"Effects of berberine on proliferation, cell cycle distribution and apoptosis of human breast cancer T47D and MCF7 cell lines","volume":"18","author":"Barzegar","year":"2015","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2017.11.012_bb0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11418-013-0766-z","article-title":"Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo","volume":"68","author":"Cai","year":"2014","journal-title":"J. Nat. Med."},{"issue":"1","key":"10.1016\/j.lfs.2017.11.012_bb0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/mc.20453","article-title":"p53 cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo","volume":"48","author":"Katiyar","year":"2009","journal-title":"Mol. Carcinog."},{"issue":"7","key":"10.1016\/j.lfs.2017.11.012_bb0040","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1349-7006.2011.01933.x","article-title":"Berberine induces cell death in human hepatoma cells in vitro by downregulating CD147","volume":"102","author":"Hou","year":"2011","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.lfs.2017.11.012_bb0045","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1349-7006.2012.02212.x","article-title":"Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-kappaB pathway","volume":"103","author":"Goto","year":"2012","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.lfs.2017.11.012_bb0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/1414-431x20144293","article-title":"Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines","volume":"48","author":"Park","year":"2015","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"1\u20133","key":"10.1016\/j.lfs.2017.11.012_bb0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2013.02.041","article-title":"Effect of berberine on cell cycle arrest and cell survival during cerebral ischemia and reperfusion and correlations with p53\/cyclin D1 and PI3K\/Akt","volume":"708","author":"Chai","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.lfs.2017.11.012_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2011.04.021","article-title":"Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells","volume":"661","author":"Yan","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.lfs.2017.11.012_bb0065","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/CAD.0b013e328330d95b","article-title":"A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs","volume":"20","author":"Sun","year":"2009","journal-title":"Anti-Cancer Drugs"},{"issue":"2","key":"10.1016\/j.lfs.2017.11.012_bb0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/aps.2016.125","article-title":"Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive system","volume":"38","author":"Zou","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"11","key":"10.1016\/j.lfs.2017.11.012_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112937","article-title":"Transportation of berberine into HepG2, HeLa and SY5Y cells: a correlation to its anti-cancer effect","volume":"9","author":"Pang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2017.11.012_bb0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jpba.2016.09.022","article-title":"Pharmacokinetics, excretion of 8-cetylberberine and its main metabolites in rat urine","volume":"132","author":"Hu","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"11","key":"10.1016\/j.lfs.2017.11.012_bb0085","first-page":"1582","article-title":"Comparative study of pharmacokinetics and tissue distribution of 8-cetylberberine and berberine in rats","volume":"49","author":"Hu","year":"2014","journal-title":"Yao Xue Xue Bao"},{"issue":"1","key":"10.1016\/j.lfs.2017.11.012_bb0090","first-page":"1","article-title":"Cancer statistics: updated cancer burden in China preface","volume":"27","author":"Chen","year":"2015","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.lfs.2017.11.012_bb0095","first-page":"137","article-title":"Improving outcomes in lung cancer: the value of the multidisciplinary health care team","volume":"9","author":"Denton","year":"2016","journal-title":"J. Multidiscip. Healthc."},{"issue":"6","key":"10.1016\/j.lfs.2017.11.012_bb0100","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1055\/s-2007-967180","article-title":"Synthesis and antimicrobial activity of 8-alkylberberine derivatives with a long aliphatic chain","volume":"73","author":"Yang","year":"2007","journal-title":"Planta Med."},{"issue":"8","key":"10.1016\/j.lfs.2017.11.012_bb0105","first-page":"1390","article-title":"Study of antihyperlipidemic effect on rabbits of 8-alkylberberine derivatives","volume":"5","author":"Ye","year":"2011","journal-title":"J. Med. Plant Res."},{"issue":"36","key":"10.1016\/j.lfs.2017.11.012_bb0110","doi-asserted-by":"crossref","first-page":"38458","DOI":"10.18632\/oncotarget.6276","article-title":"Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer","volume":"6","author":"Schottle","year":"2015","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.lfs.2017.11.012_bb0115","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2174\/1568009043332763","article-title":"Targeting apoptosis pathways in cancer therapy","volume":"4","author":"Fulda","year":"2004","journal-title":"Curr. Cancer Drug Targets"},{"issue":"22","key":"10.1016\/j.lfs.2017.11.012_bb0120","doi-asserted-by":"crossref","first-page":"11399","DOI":"10.18632\/oncotarget.2550","article-title":"Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition","volume":"5","author":"Tamaki","year":"2014","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.lfs.2017.11.012_bb0125","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cell.2004.07.025","article-title":"Mouse development and cell proliferation in the absence of D-cyclins","volume":"118","author":"Kozar","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2017.11.012_bb0130","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.biopha.2017.09.010","article-title":"Berberine could inhibit thyroid carcinoma cells by inducing mitochondrial apoptosis, G0\/G1 cell cycle arrest and suppressing migration via PI3K-AKT and MAPK signaling pathways","volume":"95","author":"Li","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.lfs.2017.11.012_bb0135","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2013.02.041","article-title":"Effect of berberine on cell cycle arrest and cell survival during cerebral ischemia and reperfusion and correlations with p53\/cyclin D1 and PI3K\/Akt","volume":"708","author":"Chai","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"15","key":"10.1016\/j.lfs.2017.11.012_bb0140","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.1021\/jf2012584","article-title":"Growth suppression of HER2-overexpressing breast cancer cells by berberine via modulation of the HER2\/PI3K\/Akt signaling pathway","volume":"59","author":"Kuo","year":"2011","journal-title":"J. Agric. Food Chem."},{"issue":"5676","key":"10.1016\/j.lfs.2017.11.012_bb0145","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.lfs.2017.11.012_bb0150","doi-asserted-by":"crossref","first-page":"10645","DOI":"10.1021\/jf9027443","article-title":"Increased growth inhibitory effects on human cancer cells and anti-inflammatory potency of shogaols from Zingiber officinale relative to gingerols","volume":"57","author":"Sang","year":"2009","journal-title":"J. Agric. Food Chem."},{"issue":"4","key":"10.1016\/j.lfs.2017.11.012_bb0155","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12272-001-1172-y","article-title":"Cytotoxic components from the dried rhizomes of Zingiber officinale Roscoe","volume":"31","author":"Kim","year":"2008","journal-title":"Arch. Pharm. Res."},{"issue":"6805","key":"10.1016\/j.lfs.2017.11.012_bb0160","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35037710","article-title":"The biochemistry of apoptosis","volume":"407","author":"Hengartner","year":"2000","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.lfs.2017.11.012_bb0165","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"issue":"2","key":"10.1016\/j.lfs.2017.11.012_bb0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","article-title":"PI3K\/Akt signalling pathway and cancer","volume":"30","author":"Fresno Vara","year":"2004","journal-title":"Cancer Treat. Rev."},{"issue":"12","key":"10.1016\/j.lfs.2017.11.012_bb0175","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nrd1902","article-title":"Exploiting the PI3K\/AKT pathway for cancer drug discovery","volume":"4","author":"Hennessy","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2017.11.012_bb0180","doi-asserted-by":"crossref","unstructured":"M. Petrovic, D. Baskic, D. Bankovic, N. Ilic, Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer, Biomarkers 16(4) (2011) 311\u201320.","DOI":"10.3109\/1354750X.2011.560281"},{"issue":"7","key":"10.1016\/j.lfs.2017.11.012_bb0185","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1054\/bjoc.2000.1706","article-title":"Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors","volume":"84","author":"Jacot","year":"2001","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.lfs.2017.11.012_bb0190","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/IGC.0b013e31821091b5","article-title":"Performance of serum CA125 as a prognostic biomarker in patients with uterine papillary serous carcinoma","volume":"21","author":"Gupta","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"5","key":"10.1016\/j.lfs.2017.11.012_bb0195","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/resp.12317","article-title":"Increased lung cancer risk in patients with interstitial lung disease and elevated CEA and CA125 serum tumour markers","volume":"19","author":"Dai","year":"2014","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.lfs.2017.11.012_bb0200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1378\/chest.108.1.163","article-title":"Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role","volume":"108","author":"Wieskopf","year":"1995","journal-title":"Chest"},{"issue":"11\u201312","key":"10.1016\/j.lfs.2017.11.012_bb0205","first-page":"1011","article-title":"CYFRA 21-1 as a tool for distant metastasis detection in lung cancer","volume":"57","author":"Cabrera-Alarcon","year":"2011","journal-title":"Clin. Lab."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517305908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517305908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T21:43:36Z","timestamp":1569966216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320517305908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":41,"alternative-id":["S0024320517305908"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2017.11.012","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"8-Cetylberberine inhibits growth of lung cancer in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2017.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}